Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ANV600 |
Trade Name | |
Synonyms | ANV-600|ANV 600 |
Drug Descriptions |
ANV600 is composed of an anti-IL-2 antibody/IL-2 fusion protein and a PDCD1 (PD-1) binding moiety, which potentially increases CD8-positive T-cells and decreases tumor growth (Cancer Res (2023) 83 (7_Supplement): 4127). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ANV600 | ANV600 | 0 | 1 |
ANV600 + Pembrolizumab | ANV600 Pembrolizumab | 0 | 1 |